About: David Montani

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: David Montani Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Montani, David (1976-....) Montani, David (1976-....) Montani, David (1976-....) Montani, David (1976-....)
Life Event	http://www.idref.fr/092632580/birth
preferred label	Montani, David (1976-....)
name	David Montani
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
isni:identifierValid	0000000002605362
Given name	David
familyName	Montani
has biographical i...tion (Deprecated)	Directeur d'une thèse d'exercice de médecine à l'Université Paris-Est Créteil - Paris 12 (en 2017) Docteur en médecine. Professeur des Universités - Praticien Hospitalier en pneumologie (en 2019) Auteur d'une thèse d'exercice de médecine à l'Université Paris-Sud - Paris 11 (en 2005)
gender	male
ORCID iD	0000-0002-9358-6922
Scopus ID	23392928800
is sameAs of	Montani, David (1976-....) Montani, David (1976-....) Montani, David (1976-....) Montani, David (1976-....)
is Thesis advisor of	http://www.sudoc.fr/194372057/id Hypertension pulmonaire sévère associée aux maladies pulmonaires chroniques post-tabagiques bronchiques ou emphysémateuses http://www.sudoc.fr/226191575/id http://www.sudoc.fr/182053180/id http://www.sudoc.fr/225771179/id http://www.sudoc.fr/14698014X/id http://www.sudoc.fr/174232926/id http://www.sudoc.fr/250770385/id http://www.sudoc.fr/263289656/id http://www.sudoc.fr/275814572/id http://www.sudoc.fr/278546900/id http://www.sudoc.fr/25322666X/id Caractéristiques initiales et pronostic des patients suivis pour une maladie veino-occlusive pulmonaire induite par la mitomycine-C http://www.sudoc.fr/27854696X/id Apport de la technique de double transfert CO-NO pour le dépistage de l'hypertension artérielle pulmonaire héritable, données de la cohorte DELPHI-2
is Praeses of	http://www.sudoc.fr/249744457/id http://www.sudoc.fr/266460313/id
is Author of	http://www.sudoc.fr/09263320X/id Pneumologie http://www.sudoc.fr/136163688/id http://www.sudoc.fr/192062530/id http://www.sudoc.fr/149338910/id http://www.sudoc.fr/181695960/id http://www.sudoc.fr/111195365/id Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension Sotatercept for the Treatment of Pulmonary Arterial Hypertension Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort Hypoxemia during sleep and overnight rostral fluid shift in pulmonary arterial hypertension: a pilot study S152 Dexamethasone reverses established monocrotaline-induced pulmonary hypertension in rats and increases pulmonary BMPR2 expression [Adult asthma exacerbations in questions]. Investigating the association between ALK Receptor Tyrosine Kinase inhibitors and pulmonary arterial hypertension: a disproportionality analysis from the WHO pharmacovigilance database “Rehab for all!” Is it too early in pulmonary arterial hypertension? Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells Familial pulmonary arterial hypertension by KDR heterozygous loss of function https://archive-ouverte.unige.ch/unige:79555#id Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease Les manifestations pulmonaires du syndrome des antisynthétases [Pulmonary manifestations of antisynthetase syndrome] https://hal.archives-ouvertes.fr/hal-03639166#id Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease https://archive-ouverte.unige.ch/unige:169061#id Initial dual oral combination therapy in pulmonary arterial hypertension Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension. https://serval.unil.ch/notice/serval:BIB_9374BDB0F8CC#id https://archive-ouverte.unige.ch/unige:89985#id The evolving landscape of pulmonary arterial hypertension clinical trials Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease Demographics and Baseline Characteristics of Patients with Idiopathic Pulmonary Fibrosis (IPF) in a Real-World Setting: Results of 847 Patients Enrolled in the Radico-ILD Cohort in France Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naive systemic sclerosis-associated pulmonary arterial hypertension https://hal.archives-ouvertes.fr/hal-03201755#id https://hal.archives-ouvertes.fr/hal-03639168#id Association between Leflunomide and Pulmonary Hypertension Impact of Gender on the Characteristics of Patients with Idiopathic Pulmonary Fibrosis Included in the RaDiCo-ILD Cohort French practical guidelines for the diagnosis and management of IPF-2021 update, short version COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension Pulmonary arterial hypertension. The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats Characteristics and long-term outcomes of pulmonary veno-occlusive disease induced by Mitomycin-C https://hal.archives-ouvertes.fr/hal-03771806#id T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertension https://hal.archives-ouvertes.fr/hal-02967858#id Pulmonary arterial hypertension in patients treated by dasatinib. Association Between Initial Treatment Strategy and Long-term Survival in Pulmonary Arterial Hypertension ¹³¹I-labeled lipiodol-induced interstitial pneumonia: a series of 15 cases. https://hal.archives-ouvertes.fr/hal-03104056#id Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs 2022 Update of indications and contraindications for lung transplantation in France Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software